Literature DB >> 9691461

Determination of the enantiomers of albuterol in human and canine plasma by enantioselective high-performance liquid chromatography on a teicoplanin-based chiral stationary phase.

K M Fried1, P Koch, I W Wainer.   

Abstract

A sensitive enantioselective high-performance chromatographic (HPLC) method was developed validated to determine low levels of (-)-R and (+)-S-albuterol in plasma. Baseline resolution was achieved by using a teicoplanin-based chiral stationary phase with a polar organic mobile phase consisting of methanol/ acetonitrile/glacial acetic acid/diethylamine, 40:60:0.3:0.2, (v/v/v/v) and a flow-rate of 1.0 ml/min. Enantioselectivity (alpha) equaled 1.18 and resolution (RS) equaled 1.8. By using fluorescence detection maximized at 230 and 310 nm for excitation and emission, respectively, concentrations of each enantiomer could be measured down to 125 pg/ml from a 1-ml plasma sample. Initially, the method was applied to plasma samples from a small single-dose inhalation study of racemic albuterol in a human volunteer and, later, to in vivo samples from a canine inhalation study of the single enantiomer, (-)-R-albuterol. Results from the canine study showed that no chiral inversion of (-)-R-albuterol occurs in the dog.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691461     DOI: 10.1002/(SICI)1520-636X(1998)10:5<484::AID-CHIR11>3.0.CO;2-W

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  5 in total

1.  Enantiomeric disposition of inhaled, intravenous and oral racemic-salbutamol in man--no evidence of enantioselective lung metabolism.

Authors:  J K Ward; J Dow; N Dallow; P Eynott; S Milleri; G P Ventresca
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

Review 2.  Considerations on HILIC and polar organic solvent-based separations: use of cyclodextrin and macrocyclic glycopetide stationary phases.

Authors:  Chunlei Wang; Chunxia Jiang; Daniel W Armstrong
Journal:  J Sep Sci       Date:  2008-06       Impact factor: 3.645

3.  Beta2-Agonist Doping Control and Optical Isomer Challenges.

Authors:  Glenn A Jacobson; J Paul Fawcett
Journal:  Sports Med       Date:  2016-12       Impact factor: 11.136

4.  A population analysis of nebulized (R)-albuterol in dogs using a novel mixed gut-lung absorption PK-PD model.

Authors:  B Auclair; I W Wainer; K Fried; P Koch; T P Jerussi; M P Ducharme
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

5.  Direct enantiomeric resolution of betaxolol with application to analysis of pharmaceutical products.

Authors:  Mohamed M Hefnawy; Maha A Sultan; Mona M Al-Shehri
Journal:  Anal Chem Insights       Date:  2007-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.